PYRIMIDINE DERIVATIVES Russian patent published in 2010 - IPC C07D239/48 C07D401/12 C07D401/14 C07D403/12 C07D403/14 C07D413/12 A61K31/506 A61P35/00 A61P37/00 

Abstract RU 2401260 C2

FIELD: chemistry.

SUBSTANCE: invention relates to novel pyrimidine derivatives having FAK inhibitory activity of formula (I), where R0 is hydrogen; R1 is a 5- or 6-member heterocycle containing 1 or 2 nitrogen atoms substituted with (C1-C7)alkyl, hydroxyl group, dialkylamino group or a 6-member heterocycle containing one nitrogen atom; R2 is hydrogen; R3 is carbamoyl substituted once or twice with (C1-C7)alkyl; a 5-member heterocycle containing 4 nitrogen atoms; SO2N(R12)R13, where R12 is hydrogen or (lower)alkyl, and R13 is hydrogen, (C1-C7)alkyl, (C1-C7)alkoxy(C1-C7)alkyl, di(C1-C7)alkylamino(C1-C7)alkyl, hydroxy(C1-C7)alkyl, or R12 and R13 together a nitrogen atom with which they are bonded form a 6-member heterocycle containing two nitrogen atoms, where the said heterocycle is not substituted or substituted with (C1-C7)alkyl; R4 is hydrogen; R5 is a halide; R6 is hydrogen; R7 is hydrogen; (C1-C7)alkoxy; carbamoyl which is not substituted or substituted with (lower)alkyl; a 5- or 6-member heterocycle containing 1 or 2 nitrogen or oxygen atoms, unsubstituted or substituted with di(C1-C7)alkylamino, (C1-C7)alkyl, hydroxy, 6-member heterocycle containing 1 or 2 nitrogen or oxygen ring atoms, unsubstituted or substituted with (C1-C7)alkyl; 6-member heterocycle-oxy containing 1 nitrogen ring atom, unsubstituted or substituted with (C1-C7)alkyl; heterocycle(C1-C7)alkyloxy, where heterocycle denotes a 5- or 6-member heterocycle containing 1 or 2 nitrogen or oxygen ring atoms which is not substituted or substituted with (C1-C7)alkyl; R8 is hydrogen; halide; (C1-C7)alkoxy, carbamoyl unsubstituted or substituted with (C1-C7)alkyl; heterocycle(C1-C7)alkyloxy, where heterocycle denotes a 5-member heterocycle containing 1 nitrogen ring atom, unsubstituted or substituted with (C1-C7)alkyl; 5- or 6-member heterocycle containing 1 or 2 nitrogen or oxygen atoms, unsubstituted or substituted with one or two substitutes independently selected from hydroxy, (C1-C7)alkyl, aminocarbonyl and (C1-C7)alkylamino; 6-member heterocycle-oxy, containing 1 nitrogen ring atom, unsubstituted or substituted 1-5 times with (C1-C7)alkyl or di(C1-C7)alkylamino; or R7 and R8 together with atoms with which they are bonded form a 6-member heterocycle containing two nitrogen or oxygen atoms, unsubstituted or substituted once or twice with (C1-C7)alkyl or oxo group; R9 is hydrogen; R10 is (C1-C7)alkoxy, as well as to their pharmaceutically acceptable salts. The invention also relates to a pharmaceutical composition and synthesis method.

EFFECT: novel compounds have useful biological activity.

4 cl, 167 ex

Similar patents RU2401260C2

Title Year Author Number
PYRIMIDINE DERIVATIVES 2005
  • Kavakhara Ehjdzhi
  • Mijaki Takakhiro
  • Rezel' Iogannes
RU2395507C2
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR 2007
  • Manli Pol U.
RU2481840C2
CONDENSED HETEROCYCLIC COMPOUND 2009
  • Li Chang Seok
  • Li Tae Khee
  • Joon Sook Kiung
  • Choj Dzeung Soon
  • Dzang Iong Dzin
  • Kim Sung Vook
  • Chang Khie Kiung
  • Park Mi Dzeong
  • Kim Tae Khun
  • Akhn Joung Kha
  • Park Khee Dong
  • Park Khiun Dzung
  • Lim Dong Chul
  • Li Dzoo Joun
  • Li Sung Khak
  • Park Van Su
  • Okh Jeong Soo
RU2480473C2
AMINOPYRIMIDINES AND PYRIDINES 2002
  • Kholi Ronald Charlz
  • Labadie Sharada Shenvi
  • Shogren Ehrik Brajan
  • Talamas Fransisko Ksav'Er
RU2308455C2
COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE 2006
  • Dzhordan Tomas A.
  • Dauling Dzhon I.
  • Chabala Dzhon Klifford
RU2419610C2
APPLICATION OF PYRIMIDYLAMINOBENZAMIDES FOR TREATMENT OF DISEASES SENSITIVE TO MODULATION OF KINASE Tie-2 ACTIVITY 2006
  • Manli Pol U.
  • Martini-Baron Georg
  • Mestan Jurgen
RU2404776C2
IMIDAZO(OR TRIAZOLO)PYRIMIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL AGENT INHIBITING SYK TYROSINE KINASE ACTIVITY 2001
  • Jura Takeshi
  • Konseps'On Arnel' B.
  • Khan Gionkhi
  • Marumo Makiko
  • Katsumata Khiroko
  • Kavamura Norikhiro
  • Kokubo Toshio
  • Komura Khiroshi
  • Li Jungfu
  • Lovinger Timoti B.
  • Mogi Muneto
  • Jamamoto Norijuki
  • Joshida Nagakhiro
  • Miller Skott
  • Popp Margaret Eh.
  • Redmann Aniko M.
  • Rodriges Marta E.
  • Skott Vil'Jam
  • Vang Ming
RU2306313C2
COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER 2007
  • Berk Gregori Piter
  • Linnartts Ronald Richard
  • Manli Pol U.
  • Versejs Richard Uill'Jam
RU2452492C2
TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS 2011
  • Demopulos Gregori A.
  • Gaitanaris Dzhordzh A.
RU2661410C2
USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS 2010
  • Bergmann John E.
  • Cutshall Neil S.
  • Demopulos Gregory A.
  • Florio Vincent A.
  • Gaitanaris George
  • Gray Patrick
  • Hohmann John
  • Onrust Rene
  • Zeng Hongkui
RU2600869C2

RU 2 401 260 C2

Authors

Imbakh Patritsija

Kavakhara Ehjdzhi

Konishi Kazukhide

Matsuura Naoko

Mijake Takakhiro

Okhmori Osamu

Resel' Iogannes

Teno Naoki

Umemura Ichiro

Dates

2010-10-10Published

2005-08-26Filed